drugset / Trial / NCT00649415

A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg Twice Daily, As Needed In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea

NCT00649415

Phase 4 Completed 154 enrolled Pfizer
RandomizedCrossoverDouble-blindTreatment

Summary

To compare the analgesic efficacy, safety, and tolerability of valdecoxib versus piroxicam in subjects with moderate to severe menstrual cramping pain associated with primary dysmenorrhea.

Timeline

Start
2003-01
Primary completion
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Piroxicam Unknown 40 mg
Comparator valdecoxib Small molecule 40 mg Oral

Indications